16:37 EDT CareDx (CDNA) up 20% at $21 after Q1 pre-announcement, Lab Products divestment
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
- CareDx to divest Lab Products unit to EuroBio for $170M cash consideration
- CareDx reports preliminary Q1 revenue roughly $118M, consensus $102.49M
- All Six AI Models Turn Cautious on CareDx (CDNA) as Profitability and Reimbursement Risks Weigh
- All Six AI Models Turn Cautious on CareDx (CDNA) as Profitability and Reimbursement Risks Weigh on Outlook
- William Blair health diagnostics analyst holds analyst/industry conference call